Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/12/17 → 10/17/23 |
Funding
- Genentech Incorporated: $326,547.77
Effect of Ocrelizumab on gray matter pathologu, leptomeningeal inflammation and cognitive dysfunction in multiple sclerosis
- Zivadinov, Robert (PI)
- Benedict, Ralph (CoI)
- Ramanathan, Murali (CoI)
- Weinstock-Guttman, Bianca (CoI)
Project: Research